News and blogs
20 results found.
Survival in people with myeloma nearly doubles since 2005
People diagnosed the blood cancer - myeloma - are now living nearly twice as long on average as they were in 2005.
Clinical trial boost with app upgrade
Blood Cancer UK react to the news that the NHS app will now allow people to sign up to clinical trials.
How are clinical trials going to help beat blood cancer in a generation?
On clinical trials day we want to celebrate the vital role clinical trials play in improving survival for people with blood cancer. Read more about how we are supporting clinical trials.
Our response to the Government's plan for UK commercial clinical trials
Refreshing clinical trials activity must benefit people with blood cancer across the UK.
Clinical trials can give people with blood cancer hope
Rachel contacted the Clinical Trials Support Service to find out whether she could potentially take part in a clinical trial and contribute to blood cancer research.
Blood Cancer UK have renewed their partnership with RareCan
Blood Cancer UK have renewed their partnership with RareCan, a digital health company. This could give people an opportunity to help researchers.
A new dawn for clinical trials
A new dawn for clinical trials to get us to a place where no lives are lost to blood cancer
Read Ed's story of being diagnosed with CLL
Ed shares his story of how our Clinical Trials Support Service helped support him through his diagnosis of CLL
My journey on a clinical trial
In this blog, James, who is living with chronic lymphocytic leukaemia, tells us about his journey with blood cancer, and discusses what research means to him.
Blood cancer drug ruxolitinib gives better outcomes than those on best-available existing medication
The drug, ruxolitinib, has been found to be better at treating the blood cancer - polycythaemia vera (PV) than the best currently available treatment.
Shibu's story - taking part in an AML clinical trial
Read Shibu's experience of being diagnosed with acute lymphoblastic leukaemia (AML), and taking part in a clinical trial after failing to find a bone marrow donor.
Supporting people with blood cancer to make decisions around clinical trials
Find out how Millie, an Advanced Nurse Practitioner, helps people with blood cancer take decisions on blood cancer clinical trials.
I put my symptoms down to being pregnant, but it was actually blood cancer.
Read Jemma's story about how her Hodgkin lymphoma symptoms were mistaken as side effects of being pregnant.
Blood cancer clinical trials - Everything you didn't know you needed to know
Read Professor Andrew Pettitt's piece on blood cancer clinical trials, where he explains the benefits, concerns and availability of clinical trials to people with blood cancer..
How we're going to make sure everyone is included in our clinical trials
Discover how Blood Cancer UK recruits people to take part in their clinical trials.
I felt like I'd hit the jackpot: My experiences on a clinical trial
Learn more about Nicky's experience of taking part in a blood cancer clinical trial to treat chronic lymphocytic leukaemia (CLL) .
Deciding to take part in a chronic lymphocytic leukaemia (CLL) clinical trial - David's story
Read how the progression of David's CLL was reversed by taking ibrutinib as part of a blood cancer clinical trial.
Jane's acute myeloid leukaemia story
Read Jane's experience of acute myeloid leukaemia (AML), including her diagnosis, treatment, clinical trial involvement and her stem cell transplant.
Joining a clinical trial for lymphoma - Johanna's story
Johanna was diagnosed with chronic lymphocytic leukemia (CLL), find out why she joined a Blood Cancer UK clinical trial to control her leukaemia.
Blood cancer patients may be denied CAR-T
Draft guidance by the NHS medicines watchdog recommends a new treatment that harnesses the immune system to fight cancer should not be available.
